154 related articles for article (PubMed ID: 18614560)
21. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease.
Hersh CP; Demeo DL; Lazarus R; Celedón JC; Raby BA; Benditt JO; Criner G; Make B; Martinez FJ; Scanlon PD; Sciurba FC; Utz JP; Reilly JJ; Silverman EK
Am J Respir Crit Care Med; 2006 May; 173(9):977-84. PubMed ID: 16456143
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response.
Chen CZ; Wang RH; Lee CH; Lin CC; Chang HY; Hsiue TR
J Formos Med Assoc; 2011 Nov; 110(11):685-9. PubMed ID: 22118311
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD.
Park JY; Chen L; Wadhwa N; Tockman MS
Int J Mol Med; 2005 Mar; 15(3):443-8. PubMed ID: 15702235
[TBL] [Abstract][Full Text] [Related]
24. EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations.
Bhaskar LV; Thangaraj K; Patel M; Shah AM; Gopal K; Saikrishna L; Tamang R; Singh L; Rao VR
Am J Drug Alcohol Abuse; 2013 Jan; 39(1):16-22. PubMed ID: 22257321
[TBL] [Abstract][Full Text] [Related]
25. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.
Hersh CP; Demeo DL; Lange C; Litonjua AA; Reilly JJ; Kwiatkowski D; Laird N; Sylvia JS; Sparrow D; Speizer FE; Weiss ST; Silverman EK
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):71-8. PubMed ID: 15817713
[TBL] [Abstract][Full Text] [Related]
26. Genetic determinants of emphysema distribution in the national emphysema treatment trial.
DeMeo DL; Hersh CP; Hoffman EA; Litonjua AA; Lazarus R; Sparrow D; Benditt JO; Criner G; Make B; Martinez FJ; Scanlon PD; Sciurba FC; Utz JP; Reilly JJ; Silverman EK
Am J Respir Crit Care Med; 2007 Jul; 176(1):42-8. PubMed ID: 17363767
[TBL] [Abstract][Full Text] [Related]
27. Functional polymorphisms of the microsomal epoxide hydrolase gene: a reappraisal on a early-onset lung cancer patients series.
Graziano C; Comin CE; Crisci C; Novelli L; Politi L; Messerini L; Andreani M; Porfirio B
Lung Cancer; 2009 Feb; 63(2):187-93. PubMed ID: 18571762
[TBL] [Abstract][Full Text] [Related]
28. Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population.
Saito S; Iida A; Sekine A; Eguchi C; Miura Y; Nakamura Y
J Hum Genet; 2001; 46(6):325-9. PubMed ID: 11393535
[TBL] [Abstract][Full Text] [Related]
29. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population.
Calikoglu M; Tamer L; Ates Aras N; Karakaş S; Ercan B
Biochem Genet; 2006 Oct; 44(7-8):307-19. PubMed ID: 16977512
[TBL] [Abstract][Full Text] [Related]
30. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
31. Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease.
Yanbaeva DG; Wouters EF; Dentener MA; Spruit MA; Reynaert NL
Free Radic Res; 2009 Aug; 43(8):738-43. PubMed ID: 19513904
[TBL] [Abstract][Full Text] [Related]
32. The relationship between polymorphisms in the glutamate cysteine ligase gene and asthma susceptibility.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Panfilov VI
Respir Med; 2007 Nov; 101(11):2422-4. PubMed ID: 17643973
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of CC16, OGG1 and GCLC polymorphisms and susceptibility to COPD.
Liu S; Li B; Zhou Y; Zhong N; Ran P
Respirology; 2007 Jan; 12(1):29-33. PubMed ID: 17207022
[TBL] [Abstract][Full Text] [Related]
34. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia.
Tumer TB; Sahin G; Arinç E
Arch Toxicol; 2012 Mar; 86(3):431-9. PubMed ID: 21983886
[TBL] [Abstract][Full Text] [Related]
35. Microsomal epoxide hydrolase genotype and risk of myocardial infarction.
Cornelis MC; El-Sohemy A; Campos H
Arch Toxicol; 2007 Sep; 81(9):641-5. PubMed ID: 17380322
[TBL] [Abstract][Full Text] [Related]
36. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
[TBL] [Abstract][Full Text] [Related]
37. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers.
Xing C; Chen Q; Li G; Zhang L; Zheng M; Zou Z; Hou L; Wang QF; Liu X; Guo X
Environ Mol Mutagen; 2013 Jul; 54(6):397-405. PubMed ID: 23797950
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing.
Makmor-Bakry M; Sills GJ; Hitiris N; Butler E; Wilson EA; Brodie MJ
Clin Neuropharmacol; 2009; 32(4):205-12. PubMed ID: 19620853
[TBL] [Abstract][Full Text] [Related]
39. Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibility.
Tilak AR; Kumar S; Jain M; Pant MC; Das BC; Guleria R; Mittal B; Mathur N; Kumar A
Cancer Invest; 2011 Jul; 29(6):411-8. PubMed ID: 21649467
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population.
Zidzik J; Slabá E; Joppa P; Kluchová Z; Dorková Z; Skyba P; Habalová V; Salagovic J; Tkácová R
Croat Med J; 2008 Apr; 49(2):182-91. PubMed ID: 18461673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
